Paxton Sues Out‑of‑State Provider Accused of Sending Abortion Pills Into Texas

Translate to Spanish or other 102 languages!

In direct violation of Texas law, Her Safe Harbor routinely sends mifepristone and misoprostol to women across state lines. Image for illustration purposes
- Advertisement -

AUSTIN – Attorney General Ken Paxton has filed a lawsuit against Debra Lynch, a Delaware-based nurse practitioner, who operates an extremist group known as Her Safe Harbor that ships abortion drugs into Texas.  

In direct violation of Texas law, Her Safe Harbor routinely sends mifepristone and misoprostol to women across state lines. The organization advertises abortion pills by mail and promises delivery to Texas within days. The lawsuit references a quote from Lynch in which she acknowledges that she and her staff “mail a lot [of abortion drugs] to Texas,” including Beaumont, Fulshear, Tomball, Houston, El Paso, and other major cities that she alludes to. 

This lawsuit follows two tragic cases in Texas in which radical abortion activists and organizations facilitated men illegally purchasing abortion-inducing drugs. According to one lawsuit, a man used the drugs to secretly poison his girlfriend, causing the death of their unborn child, and sending the mother to the hospital. 

- Advertisement -

“The day of reckoning for this radical out-of-state abortion drug trafficker is here,” said Attorney General Paxton. “No one, regardless of where they live, will be freely allowed to aid in the murder of unborn children in Texas.” 

In addition to this lawsuit, Attorney General Paxton has taken legal action against two other abortion drug providers, Plan C and Coeytaux, ordering them to immediately cease promoting, selling, or facilitating the shipment of abortion drugs to Texas residents. 

To read the lawsuit, click here

- Advertisement -
- Advertisement -

- Advertisement -

More Articles

Study: Supplement Plus Chemo Boosts Pancreatic Cancer Survival

L-glutamine, an amino acid that occurs naturally in the body and plays an important role in digestion, has been studied as a potential way to ease side effects in other cancers.

How Artificial Intelligence Is Improving Prostate Cancer Diagnostics

Mega Doctor News CLEVELAND CLINIC - September is Prostate Cancer Awareness Month.  Prostate cancer is...

FDA Approves First Drug of Its Kind for Polycythemia Vera, a Rare Blood Disorder

The U.S. Food and Drug Administration today approved Mimrylo (rusfertide), a new treatment for adults with polycythemia vera, a rare blood disorder that causes the body to make too many red blood cells.

FDA Approves First Oral Drug Indicated to Treat Dermatomyositis in Adults

Lisraya is the first FDA-approved oral treatment option for patients with dermatomyositis, addressing the high unmet need for this rare disease.
- Advertisement -